NovaBiotics highlights importance of a co-ordinated approach to antimicrobial resistance
New multi-action, multi-strain anti-infectives needed to win battle against AMR.
Dr Deborah O’Neil, CEO of NovaBiotics today stated that a multi-attack and multi-strain approach to the development of new antibiotics is the only way to meet the rising challenge of AMR.
Dr O’Neil was speaking at the ‘Focus on Anti-Infectives: Innovation for AMR’ workshop alongside companies such as Polyphor, RedX, and VICALat, at this year’s BIO International Convention in San Francisco. The workshop brought together those involved in all aspects of AMR, including industry large and small, universities, investors, expert scientific and business support, funders, policy makers and regulatory bodies.
The event was hosted by the Innovative Medicines’ Initiative (IMI), The Wellcome Trust-funded Community for Open Antimicrobial Drug Discovery and the IMI-funded European Biotechnology Networks ENABLE project. In key note speeches, they highlighted the global tools available to support the development of novel anti-infectives.
“While efforts are being made to develop new antibiotics, unless a co-ordinated approach is taken, the problem of resistance will always be an issue across fungal, bacterial and biofilm forms of infection,” said Dr O’Neil.
“We must act on infections already resistant to other antimicrobials with multiple modes of action and multi-strain attack to mitigate the evolution of resistance. In parallel, we need to combine novel anti-infectives with resistance breakers that can attack infections from all sides. Addressing the issue now and planning for the future is crucial.”
Related News
-
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar... -
News CPHI Frankfurt 2022: Innovator Interviews – Bioiberica
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We caught up with Mónica Gómez Navarro (Marketing Manager Branded Ingredients), ... -
News CPHI Frankfurt 2022: Innovator Interview – Procaps Group
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h... -
News From the floor - CPHI Frankfurt 2022
The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event. -
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc... -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance